TrialBMC psychiatry2013

Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia.

Jun Ishigooka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.